Literature DB >> 1384913

Control of cyclic AMP levels in primary cultures of human tracheal smooth muscle cells.

I P Hall1, S Widdop, P Townsend, K Daykin.   

Abstract

1. [3H]-adenosine 3':5'-cyclic monophosphate ([3H]-cyclic AMP) responses were studied in primary cultures of human tracheal smooth muscle cells derived from explants of human trachealis muscle and in short term cultures of acutely dissociated trachealis cells. 2. Isoprenaline induced concentration-dependent [3H]-cyclic AMP formation with an EC50 of 0.2 microM. The response to 10 microM isoprenaline reached a maximum after 5-10 min stimulation and remained stable for periods of up to 1 h. After 10 min stimulation, 1 microM isoprenaline produced a 9.5 fold increase over basal [3H]-cyclic AMP levels. The response to isoprenaline was inhibited by ICI 118551 (10 nM), (apparent KA 1.9 x 10(9) M-1) indicating the probable involvement of a beta 2-adrenoceptor in this response in human cultured tracheal smooth muscle cells. However, with 50 nM ICI 118551 there was a reduction in the maximum response to isoprenaline. Prostaglandin E2 also produced concentration-dependent [3H]-cyclic AMP formation (EC50 0.7 microM, response to 1 microM PGE2 6.4 fold over basal). 3. Forskolin (1 nM - 100 microM) induced concentration-dependent [3H]-cyclic AMP formation in these cells. A 1.6 fold (over basal) response was also observed following stimulation with NaF (10 mM). 4. The nonselective phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX) (0.1 mM) and the type IV, cyclic AMP selective, phosphodiesterase inhibitor rolipram (0.1 mM) both elevated basal [3H]-cyclic AMP levels by 1.8 and 1.5 fold respectively. IBMX (1-100 microM) and low concentrations of rolipram (< 10 microM), also potentiated the response to 1 microM isoprenaline. Inhibitors of the type III phosphodiesterase isoenzyme (SK&F 94120 and SK&F 94836) were without effect upon basal or isoprenaline-stimulated cyclic AMP responses in these cells.5. Carbachol (1 nM-I 00 microM) produced concentration-dependent inhibition of the [3H]-cyclic AMP response to 1 microM isoprenaline in human cultured tracheal smooth muscle cells (IC50 0.24 JM). Carbachol(1 JM) inhibited the [3H]-cyclic AMP response to 1 JM isoprenaline by 60%. This effect of carbachol was itself inhibited by atropine (50 nM) (KA 2.3 x 109 M-') indicating the involvement of a muscarinic receptor.6. These results show that primary cultures of human tracheal smooth muscle cells demonstrate cyclic AMP responses to direct receptor stimulation, adenylyl cyclase activation and inhibition with nonselective and type IV-selective cyclic AMP phosphodiesterase isoenzyme inhibitors, and that the cyclic AMP response to isoprenaline can be inhibited by muscarinic receptor stimulation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1384913      PMCID: PMC1907899          DOI: 10.1111/j.1476-5381.1992.tb12762.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  Role of intracellular Ca2+ sequestration in beta-adrenergic relaxation of a smooth muscle.

Authors:  E Mueller; C van Breemen
Journal:  Nature       Date:  1979-10-25       Impact factor: 49.962

2.  Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.

Authors:  T J Torphy; L B Cieslinski
Journal:  Mol Pharmacol       Date:  1990-02       Impact factor: 4.436

3.  The pharmacology of a beta 2-selective adrenoceptor antagonist (ICI 118,551).

Authors:  A J Bilski; S E Halliday; J D Fitzgerald; J L Wale
Journal:  J Cardiovasc Pharmacol       Date:  1983 May-Jun       Impact factor: 3.105

4.  The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors.

Authors:  M L Reeves; B K Leigh; P J England
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

5.  Modulation of fluoroaluminate-induced inositol phosphate formation by increases in tissue cyclic AMP content in bovine tracheal smooth muscle.

Authors:  I P Hall; J Donaldson; S J Hill
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

6.  Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscle.

Authors:  P J Silver; L T Hamel; M H Perrone; R G Bentley; C R Bushover; D B Evans
Journal:  Eur J Pharmacol       Date:  1988-05-20       Impact factor: 4.432

7.  Muscarinic cholinergic inhibition of cyclic AMP accumulation in airway smooth muscle. Role of a pertussis toxin-sensitive protein.

Authors:  R M Sankary; C A Jones; J M Madison; J K Brown
Journal:  Am Rev Respir Dis       Date:  1988-07

8.  Role of low Km cyclic AMP phosphodiesterase inhibition in tracheal relaxation and bronchodilation in the guinea pig.

Authors:  A L Harris; M J Connell; E W Ferguson; A M Wallace; R J Gordon; E D Pagani; P J Silver
Journal:  J Pharmacol Exp Ther       Date:  1989-10       Impact factor: 4.030

9.  Relaxing actions of procaterol, a beta 2-adrenoceptor stimulant, on smooth muscle cells of the dog trachea.

Authors:  T Fujiwara; K Sumimoto; T Itoh; H Suzuki; H Kuriyama
Journal:  Br J Pharmacol       Date:  1988-01       Impact factor: 8.739

10.  Relaxation of human peripheral airway smooth muscle in vitro does not correlate with severity of chronic airflow limitation in vivo.

Authors:  J C de Jongste; H Mons; I L Bonta; K F Kerrebijn
Journal:  Pulm Pharmacol       Date:  1989
View more
  17 in total

Review 1.  Pharmacogenetics of asthma.

Authors:  A Fenech; Ian P Hall
Journal:  Br J Clin Pharmacol       Date:  2002-01       Impact factor: 4.335

2.  Bronchodilator and anti-inflammatory activities of glaucine: In vitro studies in human airway smooth muscle and polymorphonuclear leukocytes.

Authors:  J Cortijo; V Villagrasa; R Pons; L Berto; M Martí-Cabrera; M Martinez-Losa; T Domenech; J Beleta; E J Morcillo
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

3.  beta(2)-adrenoceptor agonists inhibit release of eosinophil-activating cytokines from human airway smooth muscle cells.

Authors:  M P Hallsworth; C H Twort; T H Lee; S J Hirst
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

Review 4.  Airway smooth muscle relaxation.

Authors:  A J Knox; A E Tattersfield
Journal:  Thorax       Date:  1995-08       Impact factor: 9.139

5.  Respiratory syncytial virus infection reduces beta2-adrenergic responses in human airway smooth muscle.

Authors:  Paul E Moore; Gary Cunningham; Mark M Calder; Anthony D DeMatteo; Mark E Peeples; Marshall L Summar; R Stokes Peebles
Journal:  Am J Respir Cell Mol Biol       Date:  2006-06-08       Impact factor: 6.914

Review 6.  Cyclic nucleotide phosphodiesterases in the human lung.

Authors:  G Dent; H Magnussen; K F Rabe
Journal:  Lung       Date:  1994       Impact factor: 2.584

7.  Effects of rolipram and siguazodan on the human isolated bronchus and their interaction with isoprenaline and sodium nitroprusside.

Authors:  Y Qian; E Naline; J A Karlsson; D Raeburn; C Advenier
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

8.  Transcriptional regulation of monocyte chemotactic protein-1 release by endothelin-1 in human airway smooth muscle cells involves NF-kappaB and AP-1.

Authors:  Amy M Sutcliffe; Deborah L Clarke; Dawn A Bradbury; Lisa M Corbett; Jamie A Patel; Alan J Knox
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

Review 9.  Airway smooth muscle in asthma: just a target for bronchodilation?

Authors:  Judith L Black; Reynold A Panettieri; Audreesh Banerjee; Patrick Berger
Journal:  Clin Chest Med       Date:  2012-07-11       Impact factor: 2.878

Review 10.  Airway smooth muscle as an immunomodulatory cell.

Authors:  Gautam Damera; Omar Tliba; Reynold A Panettieri
Journal:  Pulm Pharmacol Ther       Date:  2008-12-24       Impact factor: 3.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.